These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Crystal structure of (1S,3R,8R,9R)-2,2-di-chloro-3,7,7-tri-methyl-10-methylenetri-cyclo-[6.4.0.0(1,3)]dodecan-9-ol. Benzalim A; Auhmani A; Bimoussa A; Ait Itto MY; Daran JC; Auhmani A Acta Crystallogr E Crystallogr Commun; 2016 Aug; 72(Pt 8):1163-6. PubMed ID: 27536404 [TBL] [Abstract][Full Text] [Related]
26. Crystal structure of 16-hy-droxy-4,4,10,13,14-penta-methyl-17-(6-methyl-hept-5-en-2-yl)-4,5,6,9,10,11,12,13,14,15,16,17-dodeca-hydro-1H-cyclo-penta-[a]phenanthren-3(2H)-one. Ge JJ; Chen P; Ye XX Acta Crystallogr E Crystallogr Commun; 2015 Jul; 71(Pt 7):o464-5. PubMed ID: 26279910 [TBL] [Abstract][Full Text] [Related]
27. 6-Hydroxy-salvinolone. Salae AW; Chantrapromma S; Fun HK; Karalai C Acta Crystallogr Sect E Struct Rep Online; 2009 Sep; 65(Pt 10):o2379-80. PubMed ID: 21577844 [TBL] [Abstract][Full Text] [Related]
28. (1S*,3S*,8S*,10S*)-10-Fluoro-15-oxa-tetra-cyclo-[6.6.1.0.0]penta-deca-5,12-dien-3-ol. Mehta G; Sen S Acta Crystallogr Sect E Struct Rep Online; 2011 Aug; 67(Pt 8):o1985. PubMed ID: 22091020 [TBL] [Abstract][Full Text] [Related]
29. (2S*,3S*,3aS*,6S*,7aR*)-3-Hy-droxy-2-[(2R*,3S*)-3-isopropyl-oxiran-2-yl]-3,6-dimethyl-3,3a,5,6,7,7a-hexa-hydro-1-benzofuran-4(2H)-one. Ding M; Zhang Q; Chen L; Huang N; Wang J Acta Crystallogr Sect E Struct Rep Online; 2012 Oct; 68(Pt 10):o2949. PubMed ID: 23125734 [TBL] [Abstract][Full Text] [Related]
30. (1S,2R,8R)-2,2-Dichloro-3,7,7,10-tetra-methyltricyclo-[6.4.0.0]dodec-10-en-9-one. Benharref A; El Ammari L; Berraho M Acta Crystallogr Sect E Struct Rep Online; 2010 Oct; 66(Pt 11):o2911. PubMed ID: 21589085 [TBL] [Abstract][Full Text] [Related]
31. Absolute configuration of vouaca-pen-5α-ol. Fun HK; Yodsaoue O; Chantrapromma S; Karalai C Acta Crystallogr Sect E Struct Rep Online; 2010 Jul; 66(Pt 8):o2166-7. PubMed ID: 21588448 [TBL] [Abstract][Full Text] [Related]
32. Crystal structure and Hirshfeld surface analysis of ( Mertsalov DF; Nadirova MA; Sorokina EA; Vinokurova MA; Çelikesir ST; Akkurt M; Kolesnik IA; Bhattarai A Acta Crystallogr E Crystallogr Commun; 2021 Mar; 77(Pt 3):260-265. PubMed ID: 33953948 [TBL] [Abstract][Full Text] [Related]
33. Absolute configuration of (1R,3S,8R,11R)-3,7,7,10-tetra-methyl-tri-cyclo-[6.4.0.0(1,3)]dodec-9-en-11-ol. Abdoullah B; Aziz A; Ait Itto MY; Daran JC; Abdelwahed A Acta Crystallogr Sect E Struct Rep Online; 2013; 69(Pt 8):o1308-9. PubMed ID: 24109383 [TBL] [Abstract][Full Text] [Related]
34. (E)-3,3,6,6-Tetra-methyl-9-(2-nitro-styr-yl)-3,4,5,6,7,9-hexa-hydro-1H-xanthene-1,8(2H)-dione. Lee JK; Min SJ; Cho YS; Lee KS; Cha JH Acta Crystallogr Sect E Struct Rep Online; 2012 Jun; 68(Pt 6):o1947. PubMed ID: 22719697 [TBL] [Abstract][Full Text] [Related]
38. (1S,2S,4R)-3,3-Dichloro-4,8,12,12-tetra-methyl-tricyclo-[5.5.0.0]dodeca-6,8-diene. Benharref A; El Ammari L; Berraho M; Lassaba E Acta Crystallogr Sect E Struct Rep Online; 2010 Aug; 66(Pt 9):o2463. PubMed ID: 21588782 [TBL] [Abstract][Full Text] [Related]
39. Crystal structure of (1S*,2R*)-7-benz-yloxy-2-methyl-3-tosyl-2,3,4,5-tetra-hydro-1H-3-benz-azepin-1-ol: elucidation of the relative configuration of potent allosteric GluN2B selective NMDA receptor antagonists. Tewes B; Frehland B; Fröhlich R; Wünsch B Acta Crystallogr E Crystallogr Commun; 2016 May; 72(Pt 5):683-6. PubMed ID: 27308018 [TBL] [Abstract][Full Text] [Related]
40. (E)-9-(4-Fluoro-styr-yl)-3,3,6,6-tetra-methyl-3,4,5,6,7,9-hexa-hydro-2H-xanthene-1,8-dione. Lee JK; Min SJ; Cho YS; Cha JH; Won SO Acta Crystallogr Sect E Struct Rep Online; 2013 Jun; 69(Pt 6):o985. PubMed ID: 23795137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]